A driver who uses an incretin mimetic may be certified once the treatment has been shown to be safe and effective. Does the driver require a waiting period?
A)No, there is no waiting period.
B)Yes, a six-month waiting period.
C)Yes, a one-year waiting period.
D)Yes, a two-year waiting period.

Question

Quizplus · Accepted Answer

No, there is no waiting period.
Provided the incretin mimetic has been shown to be safe and effective, there is no requirement for a waiting period. Incretin mimetics are a new class of antidiabetic drugs which involve modulation of the incretin system. Incretin mimetic drugs bind to and activate glucagon-like peptide-1 (GLP-1) receptors on pancreatic beta-cells following which insulin secretion and synthesis are initiated.

A Driver Who Uses an Incretin Mimetic May Be Certified